Quality and quantity of information in summary basis of decision documents issued by health Canada
about
Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports.Why are there deadly drugs?Postmarket safety of drugs approved by Health Canada on the basis of clinical and surrogate outcomes: a cohort study.Clinical trial transparency: many gains but access to evidence for new medicines remains imperfect.Toward a jurisprudence of drug regulation.Quality of evidence considered by Health Canada in granting full market authorisation to new drugs with a conditional approval: a retrospective cohort study.
P2860
Quality and quantity of information in summary basis of decision documents issued by health Canada
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Quality and quantity of inform ...... uments issued by health Canada
@ast
Quality and quantity of inform ...... uments issued by health Canada
@en
Quality and quantity of inform ...... uments issued by health Canada
@nl
type
label
Quality and quantity of inform ...... uments issued by health Canada
@ast
Quality and quantity of inform ...... uments issued by health Canada
@en
Quality and quantity of inform ...... uments issued by health Canada
@nl
prefLabel
Quality and quantity of inform ...... uments issued by health Canada
@ast
Quality and quantity of inform ...... uments issued by health Canada
@en
Quality and quantity of inform ...... uments issued by health Canada
@nl
P2860
P1433
P1476
Quality and quantity of inform ...... uments issued by health Canada
@en
P2093
Joel Lexchin
P2860
P304
P356
10.1371/JOURNAL.PONE.0092038
P407
P577
2014-03-20T00:00:00Z